相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel insights into macrophage diversity in rheumatoid arthritis synovium
Marie-Astrid Boutet et al.
AUTOIMMUNITY REVIEWS (2021)
Anti-commensal Ig-from enormous diversity to clear function
Tim Rollenske et al.
MUCOSAL IMMUNOLOGY (2020)
Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo
Anna Richter et al.
BMC CANCER (2020)
Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study
Fanlei Hu et al.
NATURE COMMUNICATIONS (2020)
Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support
Yasser Perera et al.
CANCERS (2020)
Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis
Yujun Tang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells
Qianwen Li et al.
BIOLOGICAL RESEARCH (2019)
Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells
Jung-Il Jung et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
In vitro combinatorial anti-proliferative and immunosuppressive effects of Brucea javanica extract with CX-4945 and imatinib in human T-cell acute lymphoblastic leukemia cells
Jung-Il Jung et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Constitutive Activation of NF-κB Pathway in Hematopoietic Stem Cells Causes Loss of Quiescence and Deregulated Transcription Factor Networks
Masahiro Marshall Nakagawa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation
Sara A. Gibson et al.
JOURNAL OF IMMUNOLOGY (2017)
Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation
Sung Woong Jang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Protein kinase CK2 in development and differentiation
Claudia Goetz et al.
BIOMEDICAL REPORTS (2017)
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors
Khalil Ahmed et al.
ONCOTARGET (2016)
Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia
Chunhua Song et al.
BLOOD (2015)
CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study
Hua Ye et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis
Fanlei Hu et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
F. Buontempo et al.
LEUKEMIA (2014)
Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
Ying Zheng et al.
CLINICAL CANCER RESEARCH (2013)
CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy
Adam Siddiqui-Jain et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The Wnt signaling pathway and rheumatoid arthritis
Francieli de Sousa Rabelo et al.
AUTOIMMUNITY REVIEWS (2010)
分享论文
